• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Increased immune escape of the new SARS-CoV-2 variant of concern Omicron.

作者信息

Hu Jie, Peng Pai, Cao Xiaoxia, Wu Kang, Chen Juan, Wang Kai, Tang Ni, Huang Ai-Long

机构信息

Key Laboratory of Molecular Biology for Infectious Diseases (Ministry of Education), Institute for Viral Hepatitis, Department of Infectious Diseases, the Second Affiliated Hospital, Chongqing Medical University, Chongqing, China.

出版信息

Cell Mol Immunol. 2022 Feb;19(2):293-295. doi: 10.1038/s41423-021-00836-z. Epub 2022 Jan 11.

DOI:10.1038/s41423-021-00836-z
PMID:35017716
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8749347/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e14a/8803963/6efea1f3b09c/41423_2021_836_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e14a/8803963/6efea1f3b09c/41423_2021_836_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e14a/8803963/6efea1f3b09c/41423_2021_836_Fig1_HTML.jpg

相似文献

1
Increased immune escape of the new SARS-CoV-2 variant of concern Omicron.新型严重急性呼吸综合征冠状病毒2（SARS-CoV-2）变异株奥密克戎的免疫逃逸能力增强。
Cell Mol Immunol. 2022 Feb;19(2):293-295. doi: 10.1038/s41423-021-00836-z. Epub 2022 Jan 11.
2
Characterization of Entry Pathways, Species-Specific Angiotensin-Converting Enzyme 2 Residues Determining Entry, and Antibody Neutralization Evasion of Omicron BA.1, BA.1.1, BA.2, and BA.3 Variants.刺突蛋白结构特征、决定病毒进入宿主细胞的物种特异性血管紧张素转换酶 2 残基，以及奥密克戎 BA.1、BA.1.1、BA.2 和 BA.3 变异株的抗体中和逃逸。
J Virol. 2022 Sep 14;96(17):e0114022. doi: 10.1128/jvi.01140-22. Epub 2022 Aug 24.
3
Mutation-induced changes in the receptor-binding interface of the SARS-CoV-2 Delta variant B.1.617.2 and implications for immune evasion.突变诱导的 SARS-CoV-2 德尔塔变异株 B.1.617.2 受体结合界面变化及其对免疫逃逸的影响。
Biochem Biophys Res Commun. 2021 Oct 15;574:14-19. doi: 10.1016/j.bbrc.2021.08.036. Epub 2021 Aug 15.
4
Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies.奥密克戎逃避了大多数现有的 SARS-CoV-2 中和抗体。
Nature. 2022 Feb;602(7898):657-663. doi: 10.1038/s41586-021-04385-3. Epub 2021 Dec 23.
5
Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies.SARS-CoV-2 B.1.1.7 对 mRNA 疫苗诱导抗体的敏感性。
Nature. 2021 May;593(7857):136-141. doi: 10.1038/s41586-021-03412-7. Epub 2021 Mar 11.
6
Where did Omicron come from? Three key theories.奥密克戎毒株源自何处？三个关键理论。
Nature. 2022 Feb;602(7895):26-28. doi: 10.1038/d41586-022-00215-2.
7
SARS-CoV-2 omicron BA.2.87.1 exhibits higher susceptibility to serum neutralization than EG.5.1 and JN.1.奥密克戎 BA.2.87.1 对血清中和的敏感性高于 EG.5.1 和 JN.1。
Emerg Microbes Infect. 2024 Dec;13(1):2359004. doi: 10.1080/22221751.2024.2359004. Epub 2024 May 31.
8
SARS-CoV-2 B.1.617 Mutations L452R and E484Q Are Not Synergistic for Antibody Evasion.严重急性呼吸综合征冠状病毒2型（SARS-CoV-2）B.1.617的L452R和E484Q突变在抗体逃逸方面不存在协同作用。
J Infect Dis. 2021 Sep 17;224(6):989-994. doi: 10.1093/infdis/jiab368.
9
The emerging plasticity of SARS-CoV-2.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）新出现的可塑性。
Science. 2021 Mar 26;371(6536):1306-1308. doi: 10.1126/science.abg4493.
10
SARS-CoV-2 escape from a highly neutralizing COVID-19 convalescent plasma.SARS-CoV-2 从高中和性的 COVID-19 恢复期血浆中逃逸。
Proc Natl Acad Sci U S A. 2021 Sep 7;118(36). doi: 10.1073/pnas.2103154118.

引用本文的文献

1
Monitoring of antibodies against SARS-CoV-2 over 2 years and characterization of immune responses following Omicron infection in a South Indian community cohort.在南印度一个社区队列中对2年期间抗SARS-CoV-2抗体的监测以及奥密克戎感染后免疫反应的特征分析。
Sci Rep. 2025 Jul 9;15(1):24756. doi: 10.1038/s41598-025-10447-7.
2
Over time analysis of the codon usage of SARS-CoV-2 and its variants.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）及其变体密码子使用情况的长期分析。
Comput Struct Biotechnol J. 2025 May 20;27:2034-2050. doi: 10.1016/j.csbj.2025.05.021. eCollection 2025.
3
Within-Host Fitness and Antigenicity Shift Are Key Factors Influencing the Prevalence of Within-Host Variations in the SARS-CoV-2 Gene.

本文引用的文献

1
Considerable escape of SARS-CoV-2 Omicron to antibody neutralization.奥密克戎对抗体中和作用的逃逸显著。
Nature. 2022 Feb;602(7898):671-675. doi: 10.1038/s41586-021-04389-z. Epub 2021 Dec 23.
2
Striking antibody evasion manifested by the Omicron variant of SARS-CoV-2.奥密克戎变异株对 SARS-CoV-2 表现出明显的抗体逃逸。
Nature. 2022 Feb;602(7898):676-681. doi: 10.1038/s41586-021-04388-0. Epub 2021 Dec 23.
3
Antibody affinity maturation and cross-variant activity following SARS-CoV-2 mRNA vaccination: Impact of prior exposure and sex.
宿主内适应性和抗原性转变是影响严重急性呼吸综合征冠状病毒2（SARS-CoV-2）基因宿主内变异流行率的关键因素。
Viruses. 2025 Mar 2;17(3):362. doi: 10.3390/v17030362.
4
The immune landscape and viral shedding of Omicron SARS-CoV-2 variants implicate immune escape.奥密克戎 SARS-CoV-2 变体的免疫格局和病毒脱落表明存在免疫逃逸。
Front Med (Lausanne). 2025 Jan 22;11:1478466. doi: 10.3389/fmed.2024.1478466. eCollection 2024.
5
Predictors of moderate, severe, and critical COVID-19 infection in a largely vaccinated kidney transplant recipient cohort during the Omicron era: the importance of timely booster vaccinations and early presentation to care.奥密克戎时代，在大部分接种疫苗的肾移植受者队列中，中度、重度和危重型新冠病毒感染的预测因素：及时接种加强针和尽早就诊的重要性
Clin Transplant Res. 2025 Mar 31;39(1):46-54. doi: 10.4285/ctr.24.0045. Epub 2025 Feb 6.
6
Single spike mutation differentiating XBB.1 and XBB.1.5 enhances SARS-CoV-2 cell-to-cell transmission and facilitates serum-mediated enhancement.区分XBB.1和XBB.1.5的单峰突变增强了新冠病毒的细胞间传播并促进了血清介导的增强作用。
Front Immunol. 2024 Nov 27;15:1501200. doi: 10.3389/fimmu.2024.1501200. eCollection 2024.
7
Robust and persistent B-cell responses following SARS-CoV-2 vaccine determine protection from SARS-CoV-2 infection.接种新冠病毒疫苗后产生强大且持久的B细胞反应可决定对新冠病毒感染的防护作用。
Front Immunol. 2024 Sep 17;15:1445653. doi: 10.3389/fimmu.2024.1445653. eCollection 2024.
8
Computationally designed Spike antigens induce neutralising responses against the breadth of SARS-COV-2 variants.通过计算设计的刺突抗原可诱导针对新冠病毒变异株广泛范围的中和反应。
NPJ Vaccines. 2024 Sep 9;9(1):164. doi: 10.1038/s41541-024-00950-9.
9
Stability of Neutralizing Antibody of PastoCoAd Vaccine Candidates against a Variant of Concern of SARS-CoV-2 in Animal Models.在动物模型中 PastoCoAd 候选疫苗对 SARS-CoV-2 关注变体的中和抗体稳定性。
Iran Biomed J. 2024 Jul 1;28(4):214-20. doi: 10.61186/ibj.3980.
10
Serological Correlates of Protection Induced by COVID-19 Vaccination in the Working Age Population: A Systematic Review and Meta-Analysis.新冠疫苗接种在工作年龄人群中诱导的保护性血清学关联：一项系统综述和荟萃分析
Vaccines (Basel). 2024 May 3;12(5):494. doi: 10.3390/vaccines12050494.
SARS-CoV-2 mRNA 疫苗接种后的抗体亲和力成熟和跨变体活性：既往暴露和性别的影响。
EBioMedicine. 2021 Dec;74:103748. doi: 10.1016/j.ebiom.2021.103748. Epub 2021 Dec 10.
4
The N501Y spike substitution enhances SARS-CoV-2 infection and transmission.N501Y 刺突突变增强了 SARS-CoV-2 的感染和传播。
Nature. 2022 Feb;602(7896):294-299. doi: 10.1038/s41586-021-04245-0. Epub 2021 Nov 24.
5
SARS-CoV-2 Delta (B.1.617.2) Variant: A Unique T478K Mutation in Receptor Binding Motif (RBM) of Gene.严重急性呼吸综合征冠状病毒2型德尔塔（B.1.617.2）变体：基因受体结合基序（RBM）中独特的T478K突变
Immune Netw. 2021 Oct 11;21(5):e32. doi: 10.4110/in.2021.21.e32. eCollection 2021 Oct.
6
Identification of SARS-CoV-2 spike mutations that attenuate monoclonal and serum antibody neutralization.鉴定导致 SARS-CoV-2 刺突突变的单克隆和血清抗体中和作用减弱的抗体。
Cell Host Microbe. 2021 Mar 10;29(3):477-488.e4. doi: 10.1016/j.chom.2021.01.014. Epub 2021 Jan 27.
7
Changes in the humoral immunity response in SARS-CoV-2 convalescent patients over 8 months.8个月内新冠康复患者体液免疫反应的变化。
Cell Mol Immunol. 2021 Feb;18(2):490-491. doi: 10.1038/s41423-020-00605-4. Epub 2021 Jan 8.
8
Spike mutation D614G alters SARS-CoV-2 fitness.刺突突变 D614G 改变了 SARS-CoV-2 的适应性。
Nature. 2021 Apr;592(7852):116-121. doi: 10.1038/s41586-020-2895-3. Epub 2020 Oct 26.
9
Development of cell-based pseudovirus entry assay to identify potential viral entry inhibitors and neutralizing antibodies against SARS-CoV-2.开发基于细胞的假病毒进入检测方法以鉴定针对严重急性呼吸综合征冠状病毒2（SARS-CoV-2）的潜在病毒进入抑制剂和中和抗体。
Genes Dis. 2020 Dec;7(4):551-557. doi: 10.1016/j.gendis.2020.07.006. Epub 2020 Jul 17.